Podocyte injury associated glomerulopathies induced by pamidronate

Podocyte injury associated glomerulopathies induced by pamidronate. Pamidronate has been demonstrated to decrease bone-related complications in multiple myeloma and delay progression of the disease. This has led to its use in supportive and maintenance therapy of myeloma in conjunction with steroids...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Kidney international 2004-02, Vol.65 (2), p.634-641
Hauptverfasser:	Barri, Yousri M., Munshi, Nikhil C., Sukumalchantra, Suteetat, Abulezz, Sameh R., Bonsib, Stephen M., Wallach, Jeffrey, Walker, Patrick D.
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Anti-Inflammatory Agents - adverse effects Biological and medical sciences Biopsy Breast Neoplasms - drug therapy Diphosphonates - adverse effects Female FSGS Glomerulonephritis Glomerulosclerosis, Focal Segmental - chemically induced Glomerulosclerosis, Focal Segmental - pathology Hematologic and hematopoietic diseases Human immunodeficiency virus Humans Immunodeficiencies. Immunoglobulinopathies Immunoglobulinopathies Immunopathology Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis Male Medical sciences Middle Aged Multiple Myeloma Multiple Myeloma - drug therapy Nephrology. Urinary tract diseases Nephropathies. Renovascular diseases. Renal failure nephrotic syndrome pamidronate proteinuria Proteinuria - chemically induced Proteinuria - pathology Urinary system involvement in other diseases. Miscellaneous Urinary tract. Prostate gland
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!